A questionnaire to collect unintended effects of transcranial magnetic stimulation: A consensus based approach.

Delphi procedure Neuromodulation Non-invasive brain stimulation Safety TMS adverse events TMS secondary effects Transcranial magnetic stimulation

Journal

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319

Informations de publication

Date de publication:
09 2022
Historique:
received: 08 12 2021
revised: 18 05 2022
accepted: 10 06 2022
pubmed: 8 7 2022
medline: 24 8 2022
entrez: 7 7 2022
Statut: ppublish

Résumé

Transcranial magnetic stimulation (TMS) has been widely used in both clinical and research practice. However, TMS might induce unintended sensations and undesired effects as well as serious adverse effects. To date, no shared forms are available to report such unintended effects. This study aimed at developing a questionnaire enabling reporting of TMS unintended effects. A Delphi procedure was applied which allowed consensus among TMS experts. A steering committee nominated a number of experts to be involved in the Delphi procedure. Three rounds were conducted before reaching a consensus. Afterwards, the questionnaire was publicized on the International Federation of Clinical Neurophysiology website to collect further suggestions by the wider scientific community. A last Delphi round was then conducted to obtain consensus on the suggestions collected during the publicization and integrate them in the questionnaire. The procedure resulted in a questionnaire, that is the TMSens_Q, applicable in clinical and research settings. Routine use of the structured TMS questionnaire and standard reporting of unintended TMS effects will help to monitor the safety of TMS, particularly when applying new protocols. It will also improve the quality of data collection as well as the interpretation of experimental findings.

Identifiants

pubmed: 35798667
pii: S1388-2457(22)00303-0
doi: 10.1016/j.clinph.2022.06.008
pii:
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101-108

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

A Giustiniani (A)

IRCCS San Camillo Hospital, Venice, Lido, Italy. Electronic address: andreina.giustiniani@hsancamillo.it.

A Vallesi (A)

Department of Neuroscience & Padova Neuroscience Center, University of Padova, Padova, Italy.

M Oliveri (M)

Department SPPEF, University of Palermo, Italy.

V Tarantino (V)

Department SPPEF, University of Palermo, Italy.

E Ambrosini (E)

Department of Neuroscience & Padova Neuroscience Center, University of Padova, Padova, Italy; Department of General Psychology, University of Padova, Italy.

M Bortoletto (M)

Neurophysiology Lab, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.

F Masina (F)

IRCCS San Camillo Hospital, Venice, Lido, Italy.

P Busan (P)

IRCCS San Camillo Hospital, Venice, Lido, Italy.

H R Siebner (HR)

Danish Research Centre for Magnetic Resonance, Centre for Functional and Diagnostic Imaging and Research, Copenhagen University Hospital - Amager and Hvidovre, Copenhagen, Denmark; Department of Neurology, Copenhagen University Hospital Bispebjerg and Frederiksberg, Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

L Fadiga (L)

Department of Neuroscience and Rehabilitation, Section of Physiology, University of Ferrara, Ferrara, Italy; Center for Translational Neurophysiology, Istituto Italiano di Tecnologia, Ferrara, Italy.

G Koch (G)

Department of Neuroscience and Rehabilitation, Section of Physiology, University of Ferrara, Ferrara, Italy; Center for Translational Neurophysiology, Istituto Italiano di Tecnologia, Ferrara, Italy.

L Leocani (L)

Department of Neurorehabilitation and Experimental Neurophysiology Unit, Institute of Experimental Neurology (INSPE), IRCCS San Raffaele, University Vita-Salute San Raffaele, Milan, Italy.

J P Lefaucheur (JP)

Clinical Neurophysiology Unit, Department of Physiology, Henri Mondor Hospital, Assistance Publique - Hôpitaux de Paris, Créteil, France; ENT Team, EA4391, Faculty of Medicine, Paris Est Créteil University, Créteil, France.

A Rotenberg (A)

Department of Neurology and the Kirby Center for Neurobiology, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.

A Zangen (A)

Department of Life Sciences and the Zlotowski Centre for Neuroscience, Ben-Gurion University, Israel.

I R Violante (IR)

School of Psychology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

V Moliadze (V)

Institute of Medical Psychology and Medical Sociology, University Medical Center Schleswig Holstein, Kiel University, Kiel, Germany.

O L Gamboa (OL)

School of Psychology, Faculty of Science, The University of Sydney, Australia.

Y Ugawa (Y)

Department of Human Neurophysiology, Fukushima Medical University, Fukushima, Japan.

A Pascual-Leone (A)

Berenson-Allen Center for Noninvasive Brain Stimulation and Division of Cognitive Neurology, Beth Israel Deaconess Medical Center and Department of Neurology, Harvard Medical School, Boston, MA, USA.

U Ziemann (U)

Department of Neurology & Stroke, University of Tübingen, Tübingen, Germany; Hertie Institute of Clinical Brain Research, University of Tübingen, Tübingen, Germany.

C Miniussi (C)

Center for Mind/Brain Sciences - CIMeC, University of Trento, Rovereto, TN, Italy.

F Burgio (F)

IRCCS San Camillo Hospital, Venice, Lido, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH